Twist Bioscience price target raised to $160 by Leerink
Leerink Partners raised its price target for Twist Bioscience to $160.00 per share from $120.00, per Benzinga’s ratings-action report.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.